Therma Bright Extends Closings of Financings and Completes Purchase of Domain Name 'coldsores.com'
Toronto, Ontario--(Newsfile Corp. - May 10, 2018) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company, announces that it will extend the closing date of its previously announced equity financing of up to $2.5 million and convertible debenture financing of up to $1.5 million, for up to thirty (30) days from the date of this release. This extension will provide investors additional time to complete and deliver their subscriptions...
2018-05-10 9:11 AM EDT
Therma Bright to Test Thermal Therapy Technology with CBD and THC for Pain Relief and Adds Dr. Steven Bennett and Bruno Maruzzo as Strategic Advisors
Toronto, Ontario--(Newsfile Corp. - May 8, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright", "Therma", or the "Company"- formerly The Jenex Corporation), a progressive medical device technology company, today is pleased to announce that it intends to conduct research into the use of its thermal therapy technology with CBD and THC. Therma Bright will conduct research in conjunction with well-known pain relief research labs and clinics. Therma proposes to collaborate with pain relief...
2018-05-08 9:27 AM EDT
Therma Bright Announces 1st Tranche Financing for $550,000 Through an Equity Private Placement and Convertible Debenture Offering
Toronto, Ontario--(Newsfile Corp. - April 27, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, announces that it has now completed a first tranche closing of its equity private placement previously announced April 19, 2018 and has issued 6,000,000 units at a price of $0.05/units for total proceeds of $300,000. Rob Fia, the Company's President & CEO, purchased 4,000,000 units for total proceeds of $200,000. Mr. Fia's...
2018-04-27 9:42 AM EDT
Therma Bright Announces: Further Testing of TherOZap(TM) Technology at Inhibiting Zika and Other Mosquito Borne Diseases, Proposed Financings and Acquisition Update
Toronto, Ontario--(Newsfile Corp. - April 19, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, provides the following updates: Therma Bright to conduct further testing of TherOZap™ technology at inhibiting Zika and other mosquito borne diseases Therma Bright announces that further to its press release on January 8, 2018 outlining results indicating effectiveness of its TherOZap™ technology in inhibiting the Zika...
2018-04-19 8:00 AM EDT
Therma Bright to Amend Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device
Toronto, Ontario--(Newsfile Corp. - April 3, 2018) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company, announces that further to its news releases on March 14, 2018 the Company has agreed to amend the definitive asset purchase agreement (the "Agreement') with the ICTV Brands group of companies, including ICTV Brands, Inc., pursuant to which it has agreed to acquire from the sellers the ClearTouch® nail phototherapy device (the...
2018-04-03 9:33 AM EDT
Therma Bright Signs Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device
Toronto, Ontario--(Newsfile Corp. - March 14, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, today is pleased to announce that further to its news releases on November 2, 2017, December 12, 2017, January 30, 2018 and March 1, 2018, the Company has now executed a definitive asset purchase agreement (the "Agreement') with the ICTV Brands group of companies, including ICTV Brands, Inc. (OTC-QX:ICTV), pursuant to which...
2018-03-14 8:00 AM EDT
Therma Bright Finalizes Terms on Acquisition, Adds Advisory Board Member and Grants Options
Toronto, Ontario--(Newsfile Corp. - March 2, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, today is pleased to announce that further to its news releases on November 2, 2017, December 12, 2017 and January 30, 2018, the Company has now finalized negotiations with the vendor and is awaiting regulatory approval for the proposed acquisition of assets that include a consumer medical device for acne and other cosmetic...
2018-03-02 8:00 AM EST
Therma Bright Announces Completion of Debt Settlements
Toronto, Ontario--(Newsfile Corp. - February 16, 2018) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company, announces that further to its news release of January 17, 2018, it has now completed certain debt settlement transactions and issued an aggregate of 2,445,150 common shares to settle an aggregate of $244,515 debt. The settled debt included the issuance to 125,000 shares to Rob Fia, CEO and a director of the Company to...
2018-02-16 9:01 AM EST
Jenex Announces Continuation to BC and Name Change to "Therma Bright Inc."
Toronto, Ontario--(Newsfile Corp. - February 7, 2018) - The Jenex Corporation (TSXV: JEN), ("Jenex" or the "Company"), a progressive medical device technology company, announces that it will be continued from the laws of Alberta to the laws of British Columbia under the Business Corporation Act (BC) effective February 8, 2018 (the "Continuation"). The Continuation was approved by the shareholders of the Company at the annual general and special meeting of shareholders held on November 15,...
2018-02-07 7:30 AM EST
Jenex Announces Non-Binding Letter of Intent with Quinsam Capital Corp. for $250,000 Investment to Develop CBD and THC Related Thermal Therapy Technology for Pain Relief and Other Pain Related Applications
Toronto, Ontario--(Newsfile Corp. - February 1, 2018) - The Jenex Corporation (TSXV: JEN) ("Jenex" or the "Company"), a progressive medical device technology company, today is pleased to announce it has entered into a non-binding letter of intent (the "LOI") with Quinsam Capital Corp. Inc. to collaborate on the development of a commercial trademarked product that will combine Jenex's thermal therapy technology with CBD or THC creams, lotions and/or oils (the "CBD/THC Thermal Device(s)")....
2018-02-01 9:00 AM EST
Jenex Completes Due Diligence on Acquisition Targets
Toronto, Ontario--(Newsfile Corp. - January 30, 2018) - The Jenex Corporation (TSXV: JEN), ("Jenex" or the "Company"), a progressive medical device technology company, today is pleased to announce that further to its news releases on November 2, 2017 and Dec 12, 2017, the Company has now completed and is satisfied with due diligence on two medical device products with established sales and cash flow. The proposed acquisition assets include a consumer medical device for acne and other cosmetic...
2018-01-30 4:41 PM EST
The Jenex Corporation Announces Board Change; Appointment of Advisory Board, Debt Settlement and Option Grants
Toronto, Ontario--(Newsfile Corp. - January 17, 2018) - The Jenex Corporation (TSXV: JEN), ("Jenex" or the "Company"), a progressive medical device technology company, today is pleased to announce the appointment of Tim Peterson as a director. In conjunction with this appointment, Tak Wing Law, the Company's Chief Financial Officer, has resigned as interim director. Mr. Peterson has a Bachelor of Arts degree in economics from the University of Western Ontario. He sat on the Board of Directors...
2018-01-17 8:08 AM EST
Jenex's TherOZap(TM) Technology Indicates Effectiveness in Inhibiting Zika Virus After Pre-Clinical Study
Toronto, Ontario--(Newsfile Corp. - January 8, 2018) - The Jenex Corporation (TSXV: JEN) ("Jenex" or the "Company"), a progressive medical device technology company, today announces that it has received results indicating effectiveness of its TherOZap™ technology in inhibiting the Zika virus. The objectives for Jenex were to engage Techna Institute at UHN in a study to assess Jenex's TherOZap™ technology for the inactivation of live Zika virus in culture media and the inhibition of Zika virus...
2018-01-08 4:57 PM EST
The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition
Toronto, Ontario--(Newsfile Corp. - December 12, 2017) - The Jenex Corporation (NEX: JEN.H) (TSXV: JEN) ("Jenex" or the "Company"), a progressive medical device technology company, today announces that the Company has met the requirements to be listed as a TSX Venture Tier 2 Company. Effective December 13, 2017, the Company's listing will transfer from NEX to TSX Venture, the Company's Tier classification will change from NEX to Tier 2 and the filing and service office will change from NEX to...
2017-12-12 9:29 AM EST
The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum
Toronto, Ontario--(Newsfile Corp. - December 4, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company"), a progressive medical device technology company, today announces that has received both shareholder and NEX Exchange approval and accordingly has closed its debt settlement arrangements with certain insiders and former insiders of the Company and issued an aggregate of 16,008,634 common shares at a deemed price of $0.05/share to settle and extinguish an aggregate of...
2017-12-04 9:23 AM EST
The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV
Toronto, Ontario--(Newsfile Corp. - November 23, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company"), a progressive medical device technology company, would like to announce the voting results from its Annual General and Special Meeting of shareholders (the "Meeting") held last week in Toronto, Ontario on November 15, 2017. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 10,439,138, representing 41.26% of the...
2017-11-23 8:46 AM EST
The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets
Toronto, Ontario--(Newsfile Corp. - November 2, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company"), a progressive medical device technology company, today announces that it has entered into a non-binding letter of intent ("LOI" or the "Proposed Acquisition") for two medical device products with established sales and cash flow (the "Acquisition Targets"). The Acquisition Targets have been sold worldwide under established brand names. The Acquisition Targets utilize thermal...
2017-11-02 8:00 AM EDT
IIROC Trade Resumption - The Jenex Corporation
Vancouver, British Columbia--(Newsfile Corp. - October 12, 2017) - Trading resumes in: Company: The Jenex Corporation
2017-10-12 1:18 PM EDT
The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)
Toronto, Ontario--(Newsfile Corp. - October 12, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company"), a progressive medical device technology company, today announces that it has received promising initial results on the Zika virus testing with TherOZap™. Dr. Alyson Kelvin at UHN reported the following: "To evaluate the effectiveness of the Jenex TherOZap™ device against the infectivity of Zika virus, cells were infected with a range of Zika virus doses and treated with the...
2017-10-12 1:12 PM EDT
IIROC Trade Halt - The Jenex Corporation
Vancouver, British Columbia--(Newsfile Corp. - October 11, 2017) - The following issues have been halted by IIROC: Company:
2017-10-11 9:12 AM EDT